JACKSON — A federal lawsuit filed this week in Mississippi claims a major pharmaceutical company made millions of dollars by misrepresenting clinical data and using sham litigation to maintain a monopoly over a drug used to treat depression and anxiety. Uniondale Chemists Inc., a retail pharmacy in Uniondale, N.Y., filed the lawsuit Tuesday in U.S. [...] [...]
OXFORD — The University of Mississippi has granted ChromaDex Corp. the exclusive worldwide patent rights to a potential new therapeutic use for pterostilbene as an anxiolytic or anti-anxiety agent. ChromaDex pTeroPure is an ultra-pure formulation of pterostilbene, a compound found in blueberries and demonstrated to have multiple health benefits. Irvine, Calif.-based ChromaDex previously licensed two [...] [...]
MADISON — Cypress Pharmaceutical announced the Food and Drug Administration (FDA) has approved a new drug application (NDA) for Zutripro (hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine HCl) Oral Solution (CIII) and Rezira (hydrocodone bitartrate and pseudoephedrine HCl) Oral Solution (CIII). Both products are indicated for the relief of cough and symptoms associated with the common [...] [...]
MADISON — Cypress Pharmaceutical Inc. has commercially launched Epinastine HCl Ophthalmic Solution, 0.05%, which is AT-rated to Allergan’s ELESTAT (epinastine HCl ophthalmic solution) 0.05%. As the first company to file an abbreviated new drug application (ANDA) containing a paragraph IV certification for this product, Cypress has been awarded a 180-day period of marketing exclusivity. Cypress, [...] [...]
JACKSON — The National Community Pharmacists Association (NCPA) has issued a statement regarding Gov. Haley Barbour signing into law S.B. 2445, which reauthorizes the Mississippi Pharmacy Practice Act and requires pharmacy benefit managers (PBMs) to be subject to oversight by the Mississippi Board of Pharmacy. B. Douglas Hoey, RPh, MBA, NCPA executive vice president and [...] [...]
WASHINGTON — A new ad campaign by the Pharmaceutical Care Management Association (PCMA) “warns Mississippi legislators that SB 2445 would increase healthcare costs by granting the State Board of Pharmacy (instead of the State Insurance Commissioner) authority to regulate pharmacy benefit managers (PBMs).” This power transfer would create a conflict of interest since the board [...] [...]
JACKSON — Mississippi Attorney General Jim Hood says he hopes a new $20-million boost to the state from a pharmaceutical lawsuit will go to mental health services. House Appropriations Committee chairman Johnny Stringer agrees with the idea. He says the budget just happens to be short $20 million and that the funds would help support [...] [...]
AMORY — Peoples Drug Company will close the doors Dec. 31, ending its run as Amory’s oldest pharmacy in Amory. A pharmacy has existed in the same location on Main Street since 1892. The pharmacy burned in 1893 and was rebuilt in 1894. The only thing saved from the fire were blue apothecary jars that [...] [...]
OXFORD — To help the University of Mississippi School of Pharmacy recruit and retain qualified students, the Pharmacy Alumni Chapter of the UM Alumni Association has created a scholarship endowment bearing its name. The group plans to fund the endowment with proceeds from the annual pharmacy weekend golf tournament and gifts from other individuals and [...] [...]
OXFORD — The University of Mississippi has received $31.7 million to expand the Thad Cochran Research Center, the primary research facility of the School of Pharmacy’s National Center for Natural Products Research. Larry Walker, NCNPR’s director since 2001, says the Health Resources and Services Administration and the U.S. Food and Drug Administration are providing $17.8 [...] [...]
Loading ...